Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study.

Ying LiChengzhi LvLin DangBingjiang LinJuan TaoChunlei ZhangXiaoyong ZhouHan MaYi LuRong ChenJinnan LiGuanshen DouYunsheng LiangYanhua LiangYu-Ling Shi

Published in: Dermatology and therapy (2024)

Most patients had psoriasis involvement in a special body area which was associated with worse QoL. Ixekizumab is similarly effective in reducing disease severity and improving QoL in patients with plaque psoriasis across different special body areas.

Keyphrases

end stage renal disease
coronary artery disease
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
systematic review
peritoneal dialysis
atopic dermatitis
prognostic factors
early onset
clinical trial
patient reported outcomes
high intensity
drug induced
patient reported